about
sameAs
A review on leukotrienes and their receptors with reference to asthmaCysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell functionCharacterization of leukotrienes in a pilot study of older asthma subjectsLeukotriene B4 receptor locus gene characterisation and association studies in asthmaTransforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1.Cysteinyl leukotriene 1 receptor expression associated with bronchial inflammation in severe exacerbations of COPDTreatment heterogeneity in asthma: genetics of response to leukotriene modifiers.Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study.Exhaled breath condensate in patients with asthma: implications for application in clinical practice.Montelukast medicines of today and tomorrow: from molecular pharmaceutics to technological formulations.Motorcycle exhaust particles augment antigen-induced airway inflammation in BALB/c mice.Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.4-thiouridine induces dose-dependent reduction of oedema, leucocyte influx and tumour necrosis factor in lung inflammation.Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma.miR-146a suppresses 5-lipoxygenase activating protein (FLAP) expression and Leukotriene B4 production in lung cancer cells.
P2860
Q28294597-BC34780A-5155-41AD-8157-FCFCF83FCAF8Q33757657-8E03E7E7-5C86-4940-9832-505BF1268872Q34008461-CE09CB50-1CB8-4DB2-8284-CDA2C338B136Q34483546-72B4FC35-AB54-40DA-A092-25DC6B8A526FQ36164138-D68DF6CC-5E0A-4D65-AA15-1D8C6BA48C41Q36181801-467646A5-4881-4ECB-9AEB-E1C270BAA8E0Q36775615-CCEE7B88-9E76-42F8-A5D7-14CAF6C0F129Q37066194-AF31F944-06CC-40F5-B073-4F3F36EB0A3DQ37114066-F54A42EB-D180-40F7-9142-75697E9C9EF2Q38787365-51DC741F-37DE-4199-B6AE-C1E68474D21CQ39832310-B1F7EFE0-9DB0-4BFD-B1D0-94AB5EC3F758Q45029735-13FB169E-FFE0-4EE4-B25B-FD64A214D753Q46214636-9A8C489D-960A-4F3F-BA73-F96105E210B2Q48297033-F0E66777-F5FA-425F-9A5B-359067872E38Q55382726-7B54D94C-E51B-4E44-844A-40564272F100
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The role of leukotrienes in asthma
@ast
The role of leukotrienes in asthma
@en
The role of leukotrienes in asthma
@nl
type
label
The role of leukotrienes in asthma
@ast
The role of leukotrienes in asthma
@en
The role of leukotrienes in asthma
@nl
prefLabel
The role of leukotrienes in asthma
@ast
The role of leukotrienes in asthma
@en
The role of leukotrienes in asthma
@nl
P1476
The role of leukotrienes in asthma
@en
P2093
Sally E Wenzel
P304
P356
10.1016/S0952-3278(03)00075-9
P407
P577
2003-01-01T00:00:00Z